Xlife Sciences AG (XLS) | WebDisclosure

Switch to English

10665	Sociétés
227292	Mots-clés
155682	Articles
120360	Communiqués

Accueil
Sociétés
Xlife Sciences AG

COMMUNIQUÉ DE PRESSE

publié le 05/02/2024 à 07:00, il y a 2 années 4 mois

Xlife Sciences AG Expands Collaboration with Department of Health Abu Dhabi, Partners with Thermo Fisher Scientific and Masdar City
Xlife Sciences AG expands collaboration with Department of Health Abu Dhabi, partners with Thermo Fisher Scientific and Masdar City to enhance global healthcare and life sciences hub

Xlife Sciences AG Department Of Health Abu Dhabi Thermo Fisher Scientific Masdar City Healthcare And Life Sciences
COMMUNIQUÉ DE PRESSE

publié le 18/10/2023 à 07:00, il y a 2 années 8 mois

Successful exit of portfolio company and major invest in AI and digital health in early cancer detection, valued at CHF 23.3 million
COMMUNIQUÉ DE PRESSE

publié le 29/09/2023 à 07:00, il y a 2 années 9 mois

ESG Report shows status quo and outlines path for future sustainability improvements Media Release Zurich, September 29, 2023
COMMUNIQUÉ DE PRESSE

publié le 21/09/2023 à 07:00, il y a 2 années 9 mois

Xlife Sciences with significant progress in H1 2023
COMMUNIQUÉ DE PRESSE

publié le 17/08/2023 à 09:45, il y a 2 années 10 mois

Collaboration of Xlife Sciences and the Department of Health – Abu Dhabi to drive global innovations in the life sciences sector
COMMUNIQUÉ DE PRESSE

publié le 20/06/2023 à 17:00, il y a 3 années

Media Release Zurich, June 20, 2023 Xlife Sciences: shareholders approved all motions at today’s AGM 2023
COMMUNIQUÉ DE PRESSE

publié le 26/05/2023 à 07:00, il y a 3 années 1 mois

Xlife Sciences publishes agenda for Annual General Meeting 2023
COMMUNIQUÉ DE PRESSE

publié le 27/04/2023 à 07:00, il y a 3 années 2 mois

Xlife Sciences: Valuation Report 2022 confirms and emphasizes long-term portfolio potential
COMMUNIQUÉ DE PRESSE

publié le 20/04/2023 à 07:00, il y a 3 années 2 mois

Xlife Sciences publishes 2022 results and 2023 outlook
COMMUNIQUÉ DE PRESSE

publié le 16/02/2023 à 07:00, il y a 3 années 4 mois

saniva diagnostics receives approval from the US FDA for its medical product NeuroMex

Les Echos

Publié le 01/07/2026 à 07:00, il y a 17 minutes

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Publié le 01/07/2026 à 07:00, il y a 17 minutes

Biophytis communique ses résultats financiers provisoires et partage ses perspectives stratégiques
Publié le 30/06/2026 à 20:52, il y a 10 heures 25 minutes

Number of shares and voting rights - May 2026 (In French only)
Publié le 30/06/2026 à 20:52, il y a 10 heures 25 minutes

Nombre total d'actions et droits de vote - mai 2026
Publié le 30/06/2026 à 18:59, il y a 12 heures 18 minutes

SUEZ has successfully completed a €600 million green bond issuance

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 01/07/2026 à 03:15, il y a 4 heures 2 minutes

GLG Life Tech Corporation Announces 2026 AGM Voting Results
Publié le 01/07/2026 à 01:00, il y a 6 heures 17 minutes

Onco-Innovations Announces Term Sheet for Notional CAD$5 Million Performance-Based Funding Arrangement and Amendments to Previously Announced Financing
Publié le 01/07/2026 à 00:00, il y a 7 heures 17 minutes

Onco-Innovations Initiates Polymer Process Development and Characterization Program for ONC010
Publié le 30/06/2026 à 23:01, il y a 8 heures 16 minutes

NextSource Materials Provides Clarification on a Prior News Release
Publié le 30/06/2026 à 22:30, il y a 8 heures 47 minutes

International Battery Metals Announces Change of Auditor

Voir tout ACCESSWIRE

EQS Group

Publié le 01/07/2026 à 07:01, il y a 15 minutes

Invitation Audio Webcast Presentation of Bossard's semi-annual results 2026
Publié le 01/07/2026 à 07:00, il y a 17 minutes

Lonza Expands Strategic Collaboration with Leading US Biopharmaceutical Company
Publié le 01/07/2026 à 07:00, il y a 17 minutes

Brockhaus Technologies AG: Closing of the sale of the stake in the Bikeleasing Group
Publié le 01/07/2026 à 07:00, il y a 17 minutes

MindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe
Publié le 01/07/2026 à 07:00, il y a 17 minutes

Paolo Doria takes over as Chief Financial Officer of Centiel